Menopause Treatment Market Research Report Information By Treatment (Hormonal Treatment, {Estrogen, Progesterone}, Combination, {Non-Hormonal Treatment, Anti-Depressants And Others}), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies And Online Stores) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

1 EXECUTIVE SUMMARY

1.1 OVERVIEW 14

1.1.1 MARKET SYNOPSIS 14

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 15

2.2 RESEARCH OBJECTIVE 15

2.3 LIST OF ASSUMPTIONS 16

3 RESEARCH METHODOLOGY

3.1.1 OVERVIEW 18

3.2 DATA MINING 18

3.3 SECONDARY RESEARCH 19

3.4 PRIMARY RESEARCH 20

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 20

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 21

3.5 FORECASTING TECHNIQUES 21

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22

3.6.1 BOTTOM-UP APPROACH 23

3.6.2 TOP-DOWN APPROACH 24

3.7 DATA TRIANGULATION 25

3.8 VALIDATION 25

4 MARKET DYNAMICS

4.1 OVERVIEW 26

4.2 DRIVERS 27

4.2.1 INCREASING OLDER FEMALE POPULATION 27

4.2.2 INCREASING PRODUCT LAUNCHES 27

4.2.3 DRIVERS IMPACT ANALYSIS 28

4.3 RESTRAINTS 28

4.3.1 SIDE-EFFECTS FROM HORMONAL TREATMENTS 28

4.3.2 RESTRAINTS IMPACT ANALYSIS 28

4.4 CHALLENGES 29

4.4.1 LACK OF AWARENESS 29

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL 30

5.1.1 THREAT OF NEW ENTRANTS 31

5.1.2 BARGAINING POWER OF SUPPLIERS 31

5.1.3 THREAT OF SUBSTITUTES 31

5.1.4 BARGAINING POWER OF BUYERS 31

5.1.5 INTENSITY OF RIVALRY 31

5.2 VALUE CHAIN ANALYSIS 32

5.2.1 R&D AND DESIGNING 33

5.2.2 MANUFACTURING 33

5.2.3 DISTRIBUTION 33

5.2.4 MARKETING & SALES 33

6 MENOPAUSE TREATMENT MARKET, BY TREATMENT

6.1 OVERVIEW 34

6.2 HORMONAL TREATMENT 36

6.3 NON-HORMONAL TREATMENT 37

7 MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

7.1 OVERVIEW 38

7.2 HOSPITAL PHARMACIES 40

7.3 RETAIL PHARMACIES 40

7.4 ONLINE STORES 41

8 GLOBAL MENOPAUSE TREATMENT MARKET, BY REGION

8.1 OVERVIEW 42

8.2 AMERICAS 44

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.2.1 NORTH AMERICA 47

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.2.1.1 US 49

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.2.1.2 CANADA 51

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.2.2 LATIN AMERICA 53

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.3 EUROPE 56

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.3.1 WESTERN EUROPE 59

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.3.1.1 GERMANY 61

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.3.1.2 FRANCE 63

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.3.1.3 UK 65

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.3.1.4 ITALY 67

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.3.1.5 SPAIN 69

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.3.1.6 REST OF WESTERN EUROPE 71

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.3.2 EASTERN EUROPE 73

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.4 ASIA-PACIFIC 76

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.4.1 JAPAN 79

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.4.2 CHINA 81

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.4.3 INDIA 83

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.4.4 AUSTRALIA 85

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.4.5 SOUTH KOREA 87

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.4.6 REST OF ASIA-PACIFIC 89

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.5 MIDDLE EAST & AFRICA 92

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.5.1 SAUDI ARABIA 94

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.5.2 UNITED ARAB EMIRATES 96

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.5.3 OMAN 98

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.5.4 KUWAIT 100

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.5.5 QATAR 102

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.5.6 REST OF MIDDLE EAST & AFRICA 104

MENOPAUSE TREATMENT MARKET, BY TREATMENT

MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW 107

9.2 COMPETITIVE BENCHMARKING 108

9.3 GLOBAL MENOPAUSE TREATMENT MARKET: COMPANY SHARE ANALYSIS 109

9.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 109

9.5 MAJOR GROWTH STRATEGY IN THE GLOBAL MENOPAUSE TREATMENT MARKET 110

9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 110

9.6.1 NEW PRODUCT LAUNCHES 110

9.6.2 ACQUISITIONS 110

9.7 FINANCIAL MATRIX 111

10 COMPANY PROFILES

10.1 PFIZER INC. 112

10.1.1 COMPANY OVERVIEW 112

10.1.2 FINANCIAL OVERVIEW 113

10.1.3 PRODUCTS/SERVICES OFFERED 113

10.1.4 KEY DEVELOPMENTS 114

10.1.5 SWOT ANALYSIS 114

10.1.6 KEY STRATEGIES 114

10.2 NOVO NORDISK A/S 115

10.2.1 COMPANY OVERVIEW 115

10.2.2 FINANCIAL OVERVIEW 115

10.2.3 PRODUCTS/SERVICES OFFERED 116

10.2.4 KEY DEVELOPMENTS 116

10.2.5 SWOT ANALYSIS 116

10.2.6 KEY STRATEGIES 117

10.3 NOVARTIS AG 118

10.3.1 COMPANY OVERVIEW 118

10.3.2 FINANCIAL OVERVIEW 118

10.3.3 PRODUCTS/SERVICES OFFERED 119

10.3.4 KEY DEVELOPMENTS 119

10.3.5 SWOT ANALYSIS 119

10.3.6 KEY STRATEGIES 120

10.4 MERCK & CO., INC. 121

10.4.1 COMPANY OVERVIEW 121

10.4.2 FINANCIAL OVERVIEW 121

10.4.3 PRODUCTS/SERVICES OFFERED 122

10.4.4 KEY DEVELOPMENTS 122

10.4.5 SWOT ANALYSIS 122

10.4.6 KEY STRATEGIES 122

10.5 ELI LILY AND COMPANY 123

10.5.1 COMPANY OVERVIEW 123

10.5.2 FINANCIAL OVERVIEW 123

10.5.3 PRODUCTS/SERVICES OFFERED 124

10.5.4 KEY DEVELOPMENTS 124

10.5.5 SWOT ANALYSIS 124

10.5.6 KEY STRATEGIES 124

10.6 ALLERGAN 125

10.6.1 COMPANY OVERVIEW 125

10.6.2 FINANCIAL OVERVIEW 125

10.6.3 PRODUCTS/SERVICES OFFERED 126

10.6.4 KEY DEVELOPMENTS 126

10.6.5 SWOT ANALYSIS 126

10.6.6 KEY STRATEGIES 126

10.7 EMCURE PHARMACEUTICALS LTD 127

10.7.1 COMPANY OVERVIEW 127

10.7.2 FINANCIAL OVERVIEW 127

10.7.3 PRODUCTS/SERVICES OFFERED 127

10.7.4 KEY DEVELOPMENTS 127

10.7.5 SWOT ANALYSIS 128

10.7.6 KEY STRATEGIES 128

10.8 CIPLA INC. 129

10.8.1 COMPANY OVERVIEW 129

10.8.2 FINANCIAL OVERVIEW 129

10.8.3 PRODUCTS/SERVICES OFFERED 129

10.8.4 KEY DEVELOPMENTS 129

10.8.5 SWOT ANALYSIS 130

10.8.6 KEY STRATEGIES 130

10.9 TEVA PHARMACEUTICALS 131

10.9.1 COMPANY OVERVIEW 131

10.9.2 FINANCIAL OVERVIEW 131

10.9.3 PRODUCTS/SERVICES OFFERED 132

10.9.4 KEY DEVELOPMENTS 132

10.9.5 SWOT ANALYSIS 132

10.9.6 KEY STRATEGIES 133

10.10 ABBOTT LABORATORIES 134

10.10.1 COMPANY OVERVIEW 134

10.10.2 FINANCIAL OVERVIEW 134

10.10.3 PRODUCTS/SERVICES OFFERED 135

10.10.4 KEY DEVELOPMENTS 135

10.10.5 SWOT ANALYSIS 135

10.10.6 KEY STRATEGIES 135

11 APPENDIX

11.1 REFERENCES 136

11.2 RELATED REPORTS 136

12 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 16

TABLE 2 GLOBAL MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 35

TABLE 3 GLOBAL MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY REGION, 2023–2032 (USD MILLION) 36

TABLE 4 GLOBAL MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 36

TABLE 5 GLOBAL MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY REGION, 2023–2032 (USD MILLION) 37

TABLE 6 GLOBAL MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 37

TABLE 7 GLOBAL MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 39

TABLE 8 GLOBAL MENOPAUSE TREATMENT MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2023–2032 (USD MILLION) 40

TABLE 9 GLOBAL MENOPAUSE TREATMENT MARKET, FOR RETAIL PHARMACIES, BY REGION, 2023–2032 (USD MILLION) 40

TABLE 10 GLOBAL MENOPAUSE TREATMENT MARKET, FOR ONLINE STORES, BY REGION, 2023–2032 (USD MILLION) 41

TABLE 11 GLOBAL MENOPAUSE TREATMENT MARKET, BY REGION, 2023–2032 (USD MILLION) 43

TABLE 12 AMERICAS: MENOPAUSE TREATMENT MARKET, BY REGION, 2023–2032 (USD MILLION) 45

TABLE 13 AMERICAS: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 45

TABLE 14 AMERICAS: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 45

TABLE 15 AMERICAS: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 46

TABLE 16 AMERICAS: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 46

TABLE 17 NORTH AMERICA: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 47

TABLE 18 NORTH AMERICA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 47

TABLE 19 NORTH AMERICA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 48

TABLE 20 NORTH AMERICA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 48

TABLE 21 NORTH AMERICA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 49

TABLE 22 US: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 49

TABLE 23 US: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 50

TABLE 24 US: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 50

TABLE 25 US: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 51

TABLE 26 CANADA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 51

TABLE 27 CANADA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 52

TABLE 28 CANADA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 52

TABLE 29 CANADA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 53

TABLE 30 LATIN AMERICA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 53

TABLE 31 LATIN AMERICA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 54

TABLE 32 LATIN AMERICA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 54

TABLE 33 LATIN AMERICA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 55

TABLE 34 EUROPE: MENOPAUSE TREATMENT MARKET, BY REGION, 2023–2032 (USD MILLION) 57

TABLE 35 EUROPE: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 57

TABLE 36 EUROPE: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 57

TABLE 37 EUROPE: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 58

TABLE 38 EUROPE: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 58

TABLE 39 WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 59

TABLE 40 WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 60

TABLE 41 WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 60

TABLE 42 WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032

(USD MILLION) 61

TABLE 43 WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 61

TABLE 44 GERMANY: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 61

TABLE 45 GERMANY: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 62

TABLE 46 GERMANY: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 62

TABLE 47 GERMANY: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 63

TABLE 48 FRANCE: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 63

TABLE 49 FRANCE: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 64

TABLE 50 FRANCE: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 64

TABLE 51 FRANCE: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 65

TABLE 52 UK: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 65

TABLE 53 UK: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 66

TABLE 54 UK: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 66

TABLE 55 UK: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 67

TABLE 56 ITALY: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 67

TABLE 57 ITALY: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 68

TABLE 58 ITALY: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 68

TABLE 59 ITALY: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 69

TABLE 60 SPAIN: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 69

TABLE 61 SPAIN: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 70

TABLE 62 SPAIN: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 70

TABLE 63 SPAIN: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 71

TABLE 64 REST OF WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 71

TABLE 65 REST OF WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032

(USD MILLION) 72

TABLE 66 REST OF WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032

(USD MILLION) 72

TABLE 67 REST OF WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 73

TABLE 68 EASTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 73

TABLE 69 EASTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 74

TABLE 70 EASTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 74

TABLE 71 EASTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 75

TABLE 72 ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 77

TABLE 73 ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 77

TABLE 74 ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 78

TABLE 75 ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 78

TABLE 76 ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 79

TABLE 77 JAPAN: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 79

TABLE 78 JAPAN: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 80

TABLE 79 JAPAN: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 80

TABLE 80 JAPAN: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 81

TABLE 81 CHINA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 81

TABLE 82 CHINA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 82

TABLE 83 CHINA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 82

TABLE 84 CHINA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 83

TABLE 85 INDIA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 83

TABLE 86 INDIA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 84

TABLE 87 INDIA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 84

TABLE 88 INDIA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 85

TABLE 89 AUSTRALIA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 85

TABLE 90 AUSTRALIA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 86

TABLE 91 AUSTRALIA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 86

TABLE 92 AUSTRALIA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 87

TABLE 93 SOUTH KOREA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 87

TABLE 94 SOUTH KOREA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 88

TABLE 95 SOUTH KOREA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 88

TABLE 96 SOUTH KOREA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 89

TABLE 97 REST OF ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 89

TABLE 98 REST OF ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 90

TABLE 99 REST OF ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032

(USD MILLION) 90

TABLE 100 REST OF ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 91

TABLE 101 MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 92

TABLE 102 MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 93

TABLE 103 MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032

(USD MILLION) 93

TABLE 104 MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032

(USD MILLION) 94

TABLE 105 MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 94

TABLE 106 SAUDI ARABIA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 94

TABLE 107 SAUDI ARABIA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 95

TABLE 108 SAUDI ARABIA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 95

TABLE 109 SAUDI ARABIA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 96

TABLE 110 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 96

TABLE 111 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032

(USD MILLION) 97

TABLE 112 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032

(USD MILLION) 97

TABLE 113 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 98

TABLE 114 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 98

TABLE 115 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032

(USD MILLION) 99

TABLE 116 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032

(USD MILLION) 99

TABLE 117 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 100

TABLE 118 KUWAIT: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 100

TABLE 119 KUWAIT: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 101

TABLE 120 KUWAIT: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 101

TABLE 121 KUWAIT: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 102

TABLE 122 QATAR: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 102

TABLE 123 QATAR: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 103

TABLE 124 QATAR: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032 (USD MILLION) 103

TABLE 125 QATAR: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 104

TABLE 126 REST OF MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023–2032 (USD MILLION) 104

TABLE 127 REST OF MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2023–2032

(USD MILLION) 105

TABLE 128 REST OF MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2023–2032

(USD MILLION) 105

TABLE 129 REST OF MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023–2032 (USD MILLION) 106

TABLE 130 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE MENOPAUSE TREATMENT MARKET 109

TABLE 131 NEW PRODUCT LAUNCHES 110

TABLE 132 ACQUISITIONS 110

TABLE 133 PFIZER INC.: PRODUCTS/SERVICES OFFERED 113

TABLE 134 NOVO NORDISK A/S: PRODUCTS/SERVICES OFFERED 116

TABLE 135 NOVARTIS AG: PRODUCTS/SERVICES OFFERED 119

TABLE 136 MERCK & CO., INC.: PRODUCTS/SERVICES OFFERED 122

TABLE 137 ELI LILY AND COMPANY: PRODUCTS/SERVICES OFFERED 124

TABLE 138 ALLERGAN: PRODUCTS/SERVICES OFFERED 126

TABLE 139 EMCURE PHARMACEUTICALS LTD: PRODUCTS/SERVICES OFFERED 127

TABLE 140 CIPLA INC.: PRODUCTS/SERVICES OFFERED 129

TABLE 141 CIPLA INC.: KEY DEVELOPMENTS 129

TABLE 142 TEVA PHARMACEUTICALS: PRODUCTS/SERVICES OFFERED 132

TABLE 143 TEVA PHARMACEUTICALS: KEY DEVELOPMENTS 132

13 LIST OF FIGURES

FIGURE 1 GLOBAL MENOPAUSE TREATMENT MARKET STRUCTURE 17

FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 23

FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL MENOPAUSE TREATMENT MARKET 26

FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL MENOPAUSE TREATMENT MARKET 30

FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL MENOPAUSE TREATMENT MARKET 32

FIGURE 6 GLOBAL MENOPAUSE TREATMENT MARKET SHARE, BY TREATMENT, 2023 (%) 34

FIGURE 7 GLOBAL MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2023 AND 2032 (USD MILLION) 35

FIGURE 8 GLOBAL MENOPAUSE TREATMENT MARKET SHARE, BY DISTRIBUTION CHANNEL, 2023 (%) 38

FIGURE 9 GLOBAL MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2023 AND 2032 (USD MILLION) 39

FIGURE 10 GLOBAL MENOPAUSE TREATMENT MARKET SHARE, BY REGION, 2023 (%) 42

FIGURE 11 GLOBAL MENOPAUSE TREATMENT MARKET, BY REGION, 2023 AND 2032 (USD MILLION) 43

FIGURE 12 AMERICAS: MENOPAUSE TREATMENT MARKET, BY REGION, 2023 AND 2032 (USD MILLION) 44

FIGURE 13 NORTH AMERICA: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION) 47

FIGURE 14 EUROPE: MENOPAUSE TREATMENT MARKET, BY REGION, 2023 AND 2032 (USD MILLION) 56

FIGURE 15 WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION) 59

FIGURE 16 ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION) 76

FIGURE 17 MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION) 92

FIGURE 18 BENCHMARKING OF MAJOR COMPETITORS 108

FIGURE 19 MAJOR MANUFACTURERS COMPANY SHARE ANALYSIS, 2023 (%) 109

FIGURE 20 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL MENOPAUSE TREATMENT MARKET 110

FIGURE 21 SALES & OPERATING INCOME MARGIN, 2023 111

FIGURE 22 R&D EXPENDITURE, 2023 111

FIGURE 23 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT 113

FIGURE 24 PFIZER INC.: SWOT ANALYSIS 114

FIGURE 25 NOVO NORDISK A/S: FINANCIAL OVERVIEW SNAPSHOT 115

FIGURE 26 NOVO NORDISK A/S: SWOT ANALYSIS 116

FIGURE 27 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT 118

FIGURE 28 NOVARTIS AG: SWOT ANALYSIS 119

FIGURE 29 MERCK & CO., INC.: FINANCIAL OVERVIEW SNAPSHOT 121

FIGURE 30 MERCK & CO., INC.: SWOT ANALYSIS 122

FIGURE 31 ELI LILY AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT 123

FIGURE 32 ELI LILY AND COMPANY: SWOT ANALYSIS 124

FIGURE 33 ALLERGAN: FINANCIAL OVERVIEW SNAPSHOT 125

FIGURE 34 ALLERGAN: SWOT ANALYSIS 126

FIGURE 35 EMCURE PHARMACEUTICALS LTD: SWOT ANALYSIS 128

FIGURE 36 CIPLA INC.: SWOT ANALYSIS 130

FIGURE 37 TEVA PHARMACEUTICALS: FINANCIAL OVERVIEW SNAPSHOT 131

FIGURE 38 TEVA PHARMACEUTICALS: SWOT ANALYSIS 132

FIGURE 39 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT 134